{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT03033524: Phase 2 Interventional Completed Recurrent Glioblastoma
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02345070: Phase 2 Interventional Completed Idiopathic Pulmonary Fibrosis
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:iodine (¹²⁴I) evuzamitide [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00914914: Phase 1 Interventional Completed Refractory Solid Tumors
(2009)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02514239: Phase 1 Interventional Completed Multiple Myeloma
(2015)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04627025: Phase 3 Interventional Completed Short Bowel Syndrome
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03224819: Early Phase 1 Interventional Terminated Acute Myeloid Leukemia
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03188666: Phase 2 Interventional Completed Fibrodysplasia Ossificans Progressiva
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04557020: Phase 3 Interventional Recruiting Nasopharyngeal Carcinoma
(2020)
Source URL:
Class:
PROTEIN
